Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. The company is headquartered in Dallas, Texas.
| Revenue (TTM) | 414,580 |
| Gross Profit (TTM) | 217,320 |
| EBITDA | $-15.95M |
| Operating Margin | -4588.00% |
| Return on Equity | -113.90% |
| Return on Assets | -60.60% |
| Revenue/Share (TTM) | $0.03 |
| Book Value | $0.79 |
| Price-to-Book | 0.47 |
| Price-to-Sales (TTM) | 15.33 |
| EV/Revenue | 15.62 |
| EV/EBITDA | -0.51 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -37.90% |
| Shares Outstanding | $17.17M |
| Float | $13.43M |
| % Insiders | 10.04% |
| % Institutions | 4.81% |